Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-04-04

Clinical Trial Update: Prevention of Postpartum Depression: A Pilot Placebo-controlled Trial of Trazodone [Phase 1]

View source ↗

Summary

A Phase 1 pilot placebo-controlled trial of trazodone for preventing postpartum depression has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Trazodone (trazodone)

Snippet

Sponsor: Verinder Sharma | Conditions: Postpartum Depression | Phase 1 | Status: WITHDRAWN